| Publications | PubMed=22052944; DOI=10.1242/dmm.008409
Lahti A.L., Kujala V.J., Chapman H., Koivisto A.-P., Pekkanen-Mattila M., Kerkela E., Hyttinen J.A.K., Kontula K., Swan H., Conklin B.R., Yamanaka S., Silvennoinen O., Aalto-Setala K.
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
Dis. Model. Mech. 5:220-230(2012) PubMed=22315618; DOI=10.1155/2012/875059
Pekkanen-Mattila M., Ojala M., Kerkela E., Rajala K., Skottman H., Aalto-Setala K.
The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells.
Stem Cells Int. 2012:875059.1-875059.10(2012) PubMed=22962621; DOI=10.1371/journal.pone.0044660
Kujala K., Paavola J., Lahti A.L., Larsson K., Pekkanen-Mattila M., Viitasalo M., Lahtinen A.M., Toivonen L., Kontula K., Swan H., Laine M., Silvennoinen O., Aalto-Setala K.
Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
PLoS ONE 7:E44660-E44660(2012) PubMed=23119085; DOI=10.1371/journal.pone.0048659
Ojala M., Rajala K., Pekkanen-Mattila M., Miettinen M., Huhtala H., Aalto-Setala K.
Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
PLoS ONE 7:E48659-E48659(2012) PubMed=23341440; DOI=10.5966/sctm.2012-0047
Toivonen S., Ojala M., Hyysalo A., Ilmarinen T., Rajala K., Pekkanen-Mattila M., Aanismaa R., Lundin K., Palgi J., Weltner J., Trokovic R., Silvennoinen O., Skottman H., Narkilahti S., Aalto-Setala K., Otonkoski T.
Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
Stem Cells Transl. Med. 2:83-93(2013) PubMed=27026928; DOI=10.1186/s40064-016-1889-y
Kuusela J., Kujala V.J., Kiviaho A.L., Ojala M., Swan H., Kontula K., Aalto-Setala K.
Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.
SpringerPlus 5:234.1-234.13(2016) |
|---|